港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

高瓴概念

469.365

-7.293-1.53%

涨家数：12

跌家数：38

平家数：5

市盈率：- -

高：476.636

开：476.636

低：467.652

收：476.659

数据加载中...

全国首家！上市房企破产重整案获批，1470亿债务"清零"

建筑材料行业：25Q1基金和陆股通均加仓玻纤和新材料

广发证券股份有...

荣昌生物(688331.SH)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点

荣昌生物(688331.SH)：抗体偶联药物RC278获得药物临床试验申请受理通知书

荣昌生物：抗体偶联药物RC278临床试验申请获受理

人福医药(600079.SH)：盐酸氢吗啡酮注射液获得德国联邦药品和医疗器械管理局(BfArM)上市许可

中升控股盘中异动快速上涨5.14%

黑龙江省伊春市市场监管局友好分局持续开展医疗器械质量安全监督检查

中国质量新闻网

翰森制药(03692)出现大手买入26.4万股，成交价$21.7，涉资572.88万

阿斯达克财经

翰森制药(03692)下跌7.38%，报21.95元/股

A股医疗器械板块异动拉升，尚荣医疗直线涨停，鹿得医疗涨超9%，开立医疗、中红医疗、拱东医疗纷纷拉升。

先健科技(01302)出现大手卖出100万股，成交价$1.53，涉资153万

阿斯达克财经

中国人保、中意资产等成立股权投资合伙企业，出资额130.01亿元

美国拟大降药价，百济神州、和黄医药等港股药企股价下跌

中国首例侵入式脑机接口临床试验成功受试者通过意念玩游戏

海底捞你学不会，胖东来你学不了

中国人保中意资产等成立投资合伙企业，出资额130.01亿

美股研究社

金斯瑞生物科技盘中异动临近午盘快速下挫5.13%

金斯瑞生物科技(01548)股价下跌5.128%，现价港币$10.36

阿斯达克财经

华润啤酒：25Q1啤酒板块恢复性增长 +3.68%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1583/news?page=16"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":469.36545,"timestamp":1747296513283,"preClose":476.6587,"halted":0,"volume":532900747,"delay":0,"changeRate":-0.015301,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-7.293243,"latestTime":"05-15 16:00:00","open":476.63635,"high":476.63635,"low":467.6524,"amount":10449974022.8,"amplitude":0.018848,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"pbRate":2.24838,"peRate":21.579252,"turnoverRate":0.003753,"increases":12,"decrements":39,"flats":3,"marketCap":2661218168320,"floatMarketCap":2078722609408},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":476.63635,"amplitude":0.018848,"preClose":476.6587,"low":467.6524,"pbRate":"2.24838","latestPrice":469.36545,"volume":532900747,"delay":0,"open":476.63635,"prevYearClose":446.93042,"prevWeekClose":480.539,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":482.232,"twentyDayClose":474.257,"sixtyDayClose":468.246,"secType":"PLATE","market":"HK","turnoverRate":0.003753,"peRate":21.579252,"marketCap":2661218168320,"floatMarketCap":2078722609408,"timestamp":1747296513283,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":12,"down":38,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:16,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534161082","title":"全国首家！上市房企破产重整案获批，1470亿债务\"清零\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2534161082","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534161082?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 16:14","pubTimestamp":1747037652,"startTime":"0","endTime":"0","summary":"涅槃重生","market":"hk","thumbnail":"https://img3.gelonghui.com/35dd2-db60d53c-dfaf-45a1-b505-211ca056d0d8.jpg?guru_height=846&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/35dd2-db60d53c-dfaf-45a1-b505-211ca056d0d8.jpg?guru_height=846&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2163685","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["000656","09666","BK0174","BK0028","BK1229","BK1258","BK1542","BK1583","BK0188","BK0273"],"gpt_icon":0},{"id":"2534114212","title":"建筑材料行业：25Q1基金和陆股通均加仓玻纤和新材料","url":"https://stock-news.laohu8.com/highlight/detail?id=2534114212","media":"广发证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534114212?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 16:13","pubTimestamp":1747037592,"startTime":"0","endTime":"0","summary":"25Q1 陆股通持仓建材行业分析：配置比例为1.18%，环比降低0.05pct，超配0.27%；Q1 加仓水泥、玻纤和新材料，减仓玻璃和消费建材。Q1 北上资金继续加仓水泥，C 端消费建材趋于调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051216441394f43f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051216441394f43f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1505","601865","603737","06655","BK1563","BK1594","00914","LU1328615791.USD","BK1507","600176","BK1135","BK1583","600552","600801","600529","600585"],"gpt_icon":0},{"id":"2534134362","title":"荣昌生物(688331.SH)：维迪西妥单抗一线治疗HER2表达的尿路上皮癌Ⅲ期临床研究达到主要研究终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2534134362","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534134362?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 15:53","pubTimestamp":1747036434,"startTime":"0","endTime":"0","summary":"维迪西妥单抗联合特瑞普利单抗对比化疗治疗HER2表达的一线局部晚期或转移性尿路上皮癌的Ⅲ期临床研究，在预先设定的独立数据监察委员会中期分析中显示强阳性结果，达到PFS和OS的两项主要研究终点，研究结果具有统计学显著差异和重大临床获益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","LU2148510915.USD","LU2328871848.SGD","LU1969619763.USD","09995","BK0239","688331","BK1574","BK1161","LU1064131003.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2534213941","title":"荣昌生物(688331.SH)：抗体偶联药物RC278获得药物临床试验申请受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2534213941","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534213941?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 15:51","pubTimestamp":1747036312,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(688331.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的《受理通知书》，新型抗体偶联(ADC)药物注射用RC278的临床试验申请获得受理。RC278是由荣昌生物自主研发的一款具有First-in-Class/Best-in-Class潜质的ADC分子，该分子能特异识别一个新型肿瘤靶点，并具有创新的连接子—毒素系统，在临床前研究中展现出广谱抗肿瘤活性、良好的安全性和药代动力学特征，将为晚期实体瘤患者带来新的治疗选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688331","BK1161","LU2148510915.USD","LU2328871848.SGD","LU1969619763.USD","BK0239","LU1064131003.USD","LU1064130708.USD","BK1574","BK1583","03347","BK1141","09995","BK1576"],"gpt_icon":0},{"id":"2534321815","title":"荣昌生物：抗体偶联药物RC278临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2534321815","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534321815?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 15:40","pubTimestamp":1747035646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","BK1576","BK0239","09995","BK1161","LU2328871848.SGD","BK1574","ADC","BK1583","BK4080","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","688331","LU1064131003.USD","BK4231","03347"],"gpt_icon":0},{"id":"2534183772","title":"人福医药(600079.SH)：盐酸氢吗啡酮注射液获得德国联邦药品和医疗器械管理局(BfArM)上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2534183772","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534183772?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 15:34","pubTimestamp":1747035282,"startTime":"0","endTime":"0","summary":"智通财经APP讯，人福医药(600079.SH)发布公告，近日，公司控股子公司宜昌人福药业有限责任公司(以下简称“宜昌人福”，公司持有其80%的股权)收到德国联邦药品和医疗器械管理局(BfArM)核准签发的盐酸氢吗啡酮注射液上市许可批准信。盐酸氢吗啡酮注射液用于需使用阿片类药物镇痛的患者。本次盐酸氢吗啡酮注射液获得德国BfArM的上市许可后，可在德国进行销售，将给公司国际业务拓展带来积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","600079","BK0070","BK0239","09996","BK0012","BK0185","BK0028","BK0096","09997","BK0188","BK1583","BK1574","BK1100","159883"],"gpt_icon":0},{"id":"2534290994","title":"中升控股盘中异动 快速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534290994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534290994?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 15:08","pubTimestamp":1747033719,"startTime":"0","endTime":"0","summary":"2025年05月12日下午盘15时08分，中升控股股票出现波动，股价大幅拉升5.14%。截至发稿，该股报12.680港元/股，成交量396.861万股，换手率0.17%，振幅4.64%。中升控股股票所在的汽车零售商行业中，整体涨幅为0.36%。其相关个股中，冠轈控股、途虎-W、中升控股涨幅较大，振幅较大的相关个股有冠轈控股、和谐汽车、中建富通，振幅分别为23.84%、17.46%、16.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505121508449756ee16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505121508449756ee16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","00881","BK1239","BK1583","BK1520","LU0287142896.SGD","LU1102505762.USD","LU0173614495.USD"],"gpt_icon":0},{"id":"2534297407","title":"黑龙江省伊春市市场监管局友好分局持续开展医疗器械质量安全监督检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2534297407","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534297407?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 14:35","pubTimestamp":1747031700,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 近日，黑龙江省伊春市市场监督管理局友好分局以医疗器械年度自查为契机，持续开展医疗器械质量安全监督检查行动，深入排查医疗器械风险隐患，守牢医疗器械安全底线。全项目检查，明确细则。截至目前，共检查医疗器械经营企业12家次，暂未发现安全隐患。下一步，友好分局将持续构建严格的医疗器械监管体系，规范医疗器械经营行为，切实保障群众用械安全。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-05-12/doc-inewhtaz1337598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","09997","159883","09996","BK1222","BK1583","BK1574"],"gpt_icon":0},{"id":"2534294312","title":"翰森制药(03692)出现大手买入26.4万股，成交价$21.7，涉资572.88万","url":"https://stock-news.laohu8.com/highlight/detail?id=2534294312","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534294312?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 14:09","pubTimestamp":1747030140,"startTime":"0","endTime":"0","summary":"[大手成交]翰森制药(03692)在下午02:09出现大手买入，成交量为26.4万，成交价为港币$21.7，涉资572.88万。至目前为止，股价跌8.65%，今日最高价为$23.5，而最低价为$21.65，总成交量为2.146千万股，总成交金额港币$4.802亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2505128037/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1583","BK1589","03692"],"gpt_icon":0},{"id":"2534299619","title":"翰森制药(03692)下跌7.38%，报21.95元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2534299619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534299619?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 13:52","pubTimestamp":1747029124,"startTime":"0","endTime":"0","summary":"5月12日，翰森制药盘中下跌7.38%，截至13:52，报21.95元/股，成交4.32亿元。翰森制药集团有限公司是一家中国领先的创新驱动型制药企业，主要关注抗肿瘤、抗感染、中枢神经系统类疾病、代谢疾病及自身免疫性疾病等领域。2023年总营收突破百亿规模，其中创新产品营收占比67.9%。截至2024年年报，翰森制药营业总收入122.61亿元、净利润43.72亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/12135250301796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2534829621","title":"A股医疗器械板块异动拉升，尚荣医疗直线涨停，鹿得医疗涨超9%，开立医疗、中红医疗、拱东医疗纷纷拉升。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534829621","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534829621?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 13:48","pubTimestamp":1747028931,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["605369","BK0220","BK1574","002551","BK1100","BK0251","09997","09996","BK1222","SG9999001051.SGD","159982","BK1583","BK0101","159883","BK0028","399300","BK0077","300981","159891","300633","BK0114","SG9999006597.SGD","SG9999001069.SGD"],"gpt_icon":0},{"id":"2534329656","title":"先健科技(01302)出现大手卖出100万股，成交价$1.53，涉资153万","url":"https://stock-news.laohu8.com/highlight/detail?id=2534329656","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534329656?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 13:14","pubTimestamp":1747026840,"startTime":"0","endTime":"0","summary":"[大手成交]先健科技(01302)在下午01:14出现大手卖出，成交量为100万，成交价为港币$1.53，涉资153万。至目前为止，股价跌1.911%，今日最高价为$1.59，而最低价为$1.53，总成交量为865.8万股，总成交金额港币$1.344千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2505129442/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","BK1583","01302","BK1600"],"gpt_icon":0},{"id":"2534829378","title":"中国人保、中意资产等成立股权投资合伙企业，出资额130.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534829378","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534829378?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 13:09","pubTimestamp":1747026545,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1583","601319","BK1542","09983","BK1258","BK1229","BK0207"],"gpt_icon":0},{"id":"2534260275","title":"美国拟大降药价，百济神州、和黄医药等港股药企股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2534260275","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534260275?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 12:07","pubTimestamp":1747022846,"startTime":"0","endTime":"0","summary":"美国总统特朗普于当地时间5月11日在社交平台TruthSocial发文称，5月12日上午9时（北京时间12日21时）将在白宫签署“美国历史上最具影响力的行政命令之一”，处方药和医药产品价格“几乎会立即下降30%至80%”。美国是全球创新药最大的销售市场，在自由定价法和专利法的加持下，创新药在这里可以卖出高价，这由此吸引了众多药企进入。美国药品拟大降价的消息，引发市场关注。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505123401875821.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505123401875821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1191","BK1588","00013","BK4614","06160","BK4139","BK4531","LU2328871848.SGD","HSTECH","BK4588","LU0588546209.SGD","BK1500","HSCEI","YANG","BK1587","LU1969619763.USD","ONC","BK4526","BK4007","BK1161","BK4585","HCM","LU0307460666.USD"],"gpt_icon":1},{"id":"2534677402","title":"中国首例侵入式脑机接口临床试验成功 受试者通过意念玩游戏","url":"https://stock-news.laohu8.com/highlight/detail?id=2534677402","media":"联合早报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534677402?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:52","pubTimestamp":1747021971,"startTime":"0","endTime":"0","summary":"上观新闻称，上海阶梯医疗科技是继马斯克创立的Neuralink公司之后，全球第二家进入临床试验阶段的侵入式脑机接口企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"zaobao_highlight","url":"https://www.zaobao.com/realtime/china/story20250512-6326527","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zaobao.com/realtime/china/story20250512-6326527","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zaobao_highlight","symbols":["BK1583","BK1141","03347","BK1576"],"gpt_icon":0},{"id":"2534295569","title":"海底捞你学不会，胖东来你学不了","url":"https://stock-news.laohu8.com/highlight/detail?id=2534295569","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534295569?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:48","pubTimestamp":1747021730,"startTime":"0","endTime":"0","summary":"大家都知道胖东来的生意好，具体好到什么程度呢？不仅是生鲜，几乎所有与民生相关的产品，胖东来都采用了“超过国标，看齐欧标”的标准。不是胖东来的产品不会出问题，而是出了任何问题，胖东来绝不为自己找理由，更不会推诿扯皮，而且选择无条件的为消","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/256893","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1233","BK1583","LU2488822045.USD","BK1591","BK1589","06862","BK1604"],"gpt_icon":0},{"id":"2534262490","title":"中国人保中意资产等成立投资合伙企业，出资额130.01亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2534262490","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534262490?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:41","pubTimestamp":1747021264,"startTime":"0","endTime":"0","summary":"美股研究社讯，天眼查App显示，近日，北京保实诚源股权投资合伙企业（有限合伙）成立，执行事务合伙人为中诚资本管理（北京）有限公司，出资额130.01亿人民币，经营范围包括以私募基金从事股权投资、投资管理、资产管理等活动。合伙人信息显示，该企业由中国人保（601319）旗下人保资本保险资产管理有限公司以及中意资产管理有限责任公司、中诚资本管理（北京）有限公司共同出资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512114812a6dbabee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512114812a6dbabee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01339","BK1258","BK1127","09983","BK1583","LU1522347837.USD","LU1497733557.USD","BK1229","LU1497734951.SGD","BK1521","LU1497733631.SGD","LU1634259557.SGD","BK1550","BK1542","LU1634259391.SGD"],"gpt_icon":0},{"id":"2534926241","title":"金斯瑞生物科技盘中异动 临近午盘快速下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534926241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534926241?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:38","pubTimestamp":1747021098,"startTime":"0","endTime":"0","summary":"2025年05月12日临近午盘11时38分，金斯瑞生物科技股票出现波动，股价急速跳水5.13%。金斯瑞生物科技股票所在的生物技术行业中，整体跌幅为3.58%。金斯瑞生物科技公司简介：金斯瑞生物科技股份有限公司是一家主要从事生物科学研究及相关业务的香港投资控股公司。本次交易前，金斯瑞直接及通过其全资附属公司Probio BVI间接持有蓬勃生物71.72%股权；交易后持股比例上升至85.09%，蓬勃生物仍为其间接非全资附属公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512113819a47acbe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512113819a47acbe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01548","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD","BK1576","BK1583","HK0000320223.HKD","BK1141"],"gpt_icon":0},{"id":"2534726224","title":"金斯瑞生物科技(01548)股价下跌5.128%，现价港币$10.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2534726224","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534726224?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:38","pubTimestamp":1747021080,"startTime":"0","endTime":"0","summary":"[下跌股]金斯瑞生物科技(01548) 股价在上午11:38比前收市价下跌5.128%，现股价为港币$10.36。至目前为止，今日最高价为$10.74，而最低价为$10.36。总成交量为1.154千万股，总成交金额为港币$1.216亿。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2505121677/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","HK0000306685.HKD","BK1583","HK0000320223.HKD","HK0000306701.USD","HK0000320264.USD","01548","BK1576"],"gpt_icon":0},{"id":"2534296420","title":"华润啤酒：25Q1啤酒板块恢复性增长 +3.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534296420","media":"和讯网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534296420?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 11:03","pubTimestamp":1747019025,"startTime":"0","endTime":"0","summary":"【5 月 12 日，港股啤酒股普遍上涨】华润啤酒涨超 3%，百威亚太涨 2%，青岛啤酒股份涨 1%。东吴证券日前发布研报称，25Q1 年啤酒板块营收 200.43 亿元，同比+3.68%，归母净利润 25.19 亿元，同比+10.62%，2025 年一季度呈现恢复性增长。一方面经营节奏支撑量价表现回暖，25Q1 销量表现稳健，25Q2、25Q3 进入低基数阶段，销量节奏有望边际向好，同时中高档品类升级的大逻辑仍将持续兑现，经营层面量价边际提速可期；另一方面，当前餐饮修复节奏仍相对缓慢，期待政策加力支持餐饮渠道更快修复，对啤酒量价形成正向支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051213395294f417a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051213395294f417a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["80291","BK1589","BK1510","IE00B0169L03.USD","BK1578","LU1720050803.USD","SG9999006514.SGD","IE0008368742.USD","LU1023057109.AUD","BK1583","LU1794554557.SGD","BK1570","BK1604","BK1521","LU0359201612.USD","IE0008369823.USD","LU1328615791.USD","IE00B5MMRT66.SGD","00291","IE00B031HY20.USD","IE00BPRC5H50.USD","CRHKY","LU0359202008.SGD","BK1180","IE00B543WZ88.USD","IE0031814852.USD","IE00B29SXG58.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":16,"totalSize":766,"code":"91000000","status":"200"}]}}